Large retailers are planting their flags in healthcare with Amazon and Best Buy leading the charge to get into the market.
News & Features
NeuroSigma’s Monarch eTNS might be the first device to treat ADHD, but it is one of a growing number of technologies that occupy the burgeoning bioelectronic medicine space.
Ambulatory surgery centers (ASCs) offer opportunities to improve efficiencies and outcomes--can your products play a role?
The Sunnyvale, CA-based company has long been the top dog in surgical robotics but increased competition is right around the corner for the firm.
Seeing firsthand the limitations of current overactive bladder therapies, a urogynecology surgeon invented a wearable, non-surgical solution to the problem.
Neovasc said it had resolved the three claims of correction of patent inventorship made by Irvine, CA-based Edwards Lifesciences.
In a new report, DRG experts have highlighted four medtech innovations that they see tearing up the script.
The company is bracing for a $25 million revenue hit after FDA ordered two of its mesh products off the market, but a bigger concern may be lying in wait.
The Abbott Park, IL-based has had a solid foundation of success dating back to the closure of the St. Jude Medical acquisition.
A new exo-suit technology from ReWalk aims to help stroke survivors regain their normal gait patterns.
FDA has ordered Boston Scientific and Coloplast to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse. Patient advocates say the action was not made soon enough and does not go far enough, but it is a step in the right direction.